责任编辑：小浪快报 资料显示，宁波天益医疗器械股份有限公司位于浙江省宁波市东钱湖旅游度假区莫枝北路788号，成立 日期1998年3月12日，上市日期2022年4月7日，公司主营业务涉及血液净化及病房护理领域医用高分子 耗材等医疗器械的研发、生产与销售。主营业务收入构成为：血液净化类59.05%，病房护理类 34.08%，其他6.87%。 截至6月30日，天益医疗股东户数4196.00，较上期减少0.31%；人均流通股4372股，较上期增加0.31%。 2025年1月-6月，天益医疗实现营业收入2.27亿元，同比增长11.50%；归母净利润948.32万元，同比减少 35.23%。 分红方面，天益医疗A股上市后累计派现1.02亿元。近三年，累计派现8749.78万元。 机构持仓方面，截止2025年6月30日，天益医疗十大流通股东中，鹏华弘嘉混合A（003165）位居第四 大流通股东，持股49.87万股，持股数量较上期不变。圆信永丰聚优A（010469）位居第八大流通股东， 持股28.70万股，相比上期减少2.80万股。圆信永丰医药健康A（006274）位居第十大流通股东，持股 23.00万股，相比上期减少4.5 ...

Core Viewpoint - Tianyi Medical has experienced a decline in stock price, with a 5.05% drop on September 19, 2023, and a cumulative decline of 4.3% over three consecutive days [1] Company Overview - Tianyi Medical, established on March 12, 1998, is located in Ningbo, Zhejiang Province, and was listed on April 7, 2022. The company specializes in the research, production, and sales of medical devices, particularly in blood purification and ward care [1] - The revenue composition of Tianyi Medical is as follows: blood purification accounts for 59.05%, ward care for 34.08%, and other products for 6.87% [1] Shareholder Information - Among the top ten circulating shareholders, Penghua Fund's Penghua Hongjia Mixed A (003165) holds 498,700 shares, unchanged from the previous period, representing 2.72% of circulating shares. The estimated floating loss today is approximately 1.12 million yuan, with a cumulative floating loss of 997,400 yuan over the three-day decline [2] - Penghua Hongjia Mixed A has a total scale of 450 million yuan and has achieved a year-to-date return of 34.51%, ranking 2279 out of 8172 in its category [2] Fund Manager Performance - The fund manager of Penghua Hongjia Mixed A is Tang Zhiyuan, who has been in the position for 8 years and 69 days. The fund's total asset scale is 1.378 billion yuan, with the best return during his tenure being 177.74% and the worst being -3.8% [3][5] Fund Holdings - Penghua Anjin One-Year Holding Period Mixed A (017083) is another fund under Penghua Fund that has a significant holding in Tianyi Medical, with 66,400 shares, accounting for 1.57% of the fund's net value. The estimated floating loss today is about 149,400 yuan, with a cumulative floating loss of 132,800 yuan over the three-day decline [4] - This fund was established on March 14, 2023, with a total scale of 125 million yuan, achieving a year-to-date return of 12.25%, ranking 5434 out of 8172 in its category [4]

责任编辑：小浪快报 截至6月30日，天益医疗股东户数4196.00，较上期减少0.31%；人均流通股4372股，较上期增加0.31%。 2025年1月-6月，天益医疗实现营业收入2.27亿元，同比增长11.50%；归母净利润948.32万元，同比减少 35.23%。 分红方面，天益医疗A股上市后累计派现1.02亿元。近三年，累计派现8749.78万元。 机构持仓方面，截止2025年6月30日，天益医疗十大流通股东中，鹏华弘嘉混合A（003165）位居第四 大流通股东，持股49.87万股，持股数量较上期不变。圆信永丰聚优A（010469）位居第八大流通股东， 持股28.70万股，相比上期减少2.80万股。圆信永丰医药健康A（006274）位居第十大流通股东，持股 23.00万股，相比上期减少4.55万股。鹏华优质治理混合(LOF)A（160611）退出十大流通股东之列。 9月8日，天益医疗盘中上涨2.08%，截至09:48，报45.14元/股，成交393.43万元，换手率0.48%，总市值 26.61亿元。 天益医疗今年以来股价涨25.00%，近5个交易日涨2.13%，近20日跌4.73%，近60日涨15.71 ...

Summary of Key Points Core Viewpoint - Tianyi Medical's stock experienced a decline of 2.77% on August 28, with a trading volume of 66.35 million yuan, indicating potential market volatility and investor sentiment concerns [1]. Financing and Trading Data - On August 28, Tianyi Medical had a financing purchase amount of 10.72 million yuan and a net financing purchase of 5.96 million yuan, with a total financing and securities balance of 31.14 million yuan, accounting for 3.83% of its market capitalization [1]. - The financing balance is above the 80th percentile of the past year, indicating a high level of financing activity [1]. - There were no short sales or repayments on the same day, with the short selling balance also at zero, placing it in the 90th percentile of the past year [1]. Company Overview - Tianyi Medical, established on March 12, 1998, and listed on April 7, 2022, specializes in the research, production, and sales of medical devices, particularly in blood purification and ward care [1]. - The company's revenue composition includes 59.05% from blood purification, 34.08% from ward care, and 6.87% from other sources [1]. Financial Performance - For the first half of 2025, Tianyi Medical reported a revenue of 227 million yuan, reflecting a year-on-year growth of 11.50%, while the net profit attributable to shareholders decreased by 35.23% to 9.48 million yuan [2]. - The total number of shareholders as of June 30 was 4,196, a slight decrease of 0.31%, with an average of 4,372 circulating shares per person, which increased by 0.31% [2]. Dividend and Shareholder Information - Since its A-share listing, Tianyi Medical has distributed a total of 102 million yuan in dividends, with 87.50 million yuan distributed over the past three years [3]. - As of June 30, 2025, the top ten circulating shareholders included notable funds, with some holdings remaining stable while others saw slight reductions [3].

Summary of Key Points Core Viewpoint - Tianyi Medical (301097) has shown a significant increase in stock price, closing at 48.4 yuan on July 25, 2025, with a rise of 4.85% [1] Financial Performance - The company reported a main revenue of 98.51 million yuan in Q1 2025, reflecting a year-on-year increase of 1.65% [5] - The net profit attributable to shareholders was 4.88 million yuan, a decrease of 9.81% year-on-year [5] - The company experienced a negative non-recurring net profit of -520,700 yuan, down 123.38% year-on-year [5] - The gross profit margin stood at 33.25% [5] Market Activity - On July 25, 2025, the net inflow of main funds was 4.05 million yuan, accounting for 2.98% of the total transaction amount [1][2] - Retail investors contributed a net inflow of 3.07 million yuan, representing 2.26% of the total transaction amount [1][2] - The stock had a turnover rate of 15.33% on the same day, with a total transaction volume of 28,100 hands and a transaction amount of 136 million yuan [1] Financing and Margin Trading - On July 25, 2025, the financing balance was 39.70 million yuan, with a net financing purchase of 1.70 million yuan [3] - There were no shares sold or repaid in the margin trading segment, indicating no activity in this area [3] Industry Comparison - Tianyi Medical's total market value is 2.853 billion yuan, significantly lower than the industry average of 11.518 billion yuan [5] - The company's net asset value is 1.194 billion yuan, compared to the industry average of 3.919 billion yuan [5] - The price-to-earnings ratio (P/E) is 146.28, which is considerably higher than the industry average of 63.28 [5] - The net profit margin of 4.95% is below the industry average of 10.86% [5]